Humacyte (NASDAQ:HUMA) Receives “Buy” Rating from HC Wainwright
Humacyte (NASDAQ:HUMA – Get Free Report)‘s stock had its “buy” rating reaffirmed by HC Wainwright in a research report issued on Wednesday,Benzinga reports. They currently have a $15.00 target price on the stock. HC Wainwright’s target price suggests a potential upside of 441.52% from the stock’s current price. HUMA has been the topic of several […]
Humacyte (NASDAQ:HUMA – Get Free Report)‘s stock had its “buy” rating reaffirmed by HC Wainwright in a research report issued on Wednesday,Benzinga reports. They currently have a $15.00 target price on the stock. HC Wainwright’s target price suggests a potential upside of 441.52% from the stock’s current price. HUMA has been the topic of several […]
